Patent ID: 8802721
Filing Date: 2014-08-12
Classification: A61K,A61P,C07D,Y02A

Abstract:
1. A compound represented by structural formula (VII): or a pharmaceutically acceptable salt, solvate, or clathrate thereof, wherein: L is a linker selected from the group consisting of —NR—C(O)—, —C(O)—NR—, —NR—C(S)—, —C(S)—NR—, —NR—C(NR X X each Z is independently selected from the group consisting of a lower alkyl, a lower haloalkyl, a halo, a lower alkoxy, a lower alkyl sufanyl, cyano, nitro, or lower haloalkoxy; R, for each occurrence is independently selected from —H, an alkyl, —C(O)R R R R X X X R R R n is zero or an integer from 1 to 2; p, for each occurrence, is independently 1 or 2; and t is zero or an integer from 1 to 4.